Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimco Realty Corporation (HC) Common Stock (KIM) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Kimco Realty Corporation (HC) Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Kimco Realty Corporation (HC) Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Kimco Realty Corporation (HC) Common Stock trades at $22.48 (market cap $15.06B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Kimco Realty Corporation (HC) Common Stock is far larger — about 8.4× Vir Biotechnology Inc. Common Stock's market cap, and Kimco Realty Corporation (HC) Common Stock pays a 4.99% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kimco Realty Corporation (HC) Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

KIMVIR
Market Cap
$15.06B$1.80B
Volume
6,246,9871,782,836
Sector
Real EstateHealth
52-Week High
$26.38$11.78
52-Week Low
$19.78$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$23.22B$1.36B
Dividend Yield
4.99%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kimco Realty Corporation (HC) Common Stock

KIM trades at $22.45, up 0.58% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Fundamentals show robust profitability with a 27.76% net income margin and a P/E of 26.1. Analyst consensus is a Buy with a $26.09 price target, though technical indicators suggest near-term caution.

The outlook for KIM is mixed; strong fundamentals and positive analyst sentiment support upside, but technical bearishness and macroeconomic risks pose challenges. Investment opportunity lies in its high dividend yield and earnings growth, while risks include market volatility and real estate sector headwinds. The stock's performance will hinge on upcoming earnings and broader economic conditions.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KIM

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Kimco Realty Corporation (HC) Common Stock

Kimco Realty is a real estate investment trust that owns and operates open-air, grocery-anchored shopping centers and mixed-use properties in the United States.

Read more on KIM →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →